BCCIP was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21.
This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant BRCA2 And CDKN1A Interacting Protein (BCCIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant BRCA2 And CDKN1A Interacting Protein (BCCIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant BRCA2 And CDKN1A Interacting Protein (BCCIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to BRCA2 And CDKN1A Interacting Protein (BCCIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for BRCA2 And CDKN1A Interacting Protein (BCCIP) | ELISA Kit Customized Service Offer |
- "TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase."J. Biol. Chem. 275:31145-31154(2000) [PubMed] [Europe PMC] [Abstract]
- "Genomic structure of the human BCCIP gene and its expression in cancer."Gene 302:139-146(2003) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and comparative analysis of human chromosome 10." Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2."Oncogene 20:336-345(2001) [PubMed] [Europe PMC] [Abstract]
- "Inhibition of G1 to S cell cycle progression by BCCIP beta."Cell Cycle 3:343-348(2004) [PubMed] [Europe PMC] [Abstract]
- "BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1."Cell Cycle 3:1457-1462(2004) [PubMed] [Europe PMC] [Abstract]
- "The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair."Mol. Cell. Biol. 25:1949-1957(2005) [PubMed] [Europe PMC] [Abstract]
- "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
- "BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage."Nucleic Acids Res. 35:7160-7170(2007) [PubMed] [Europe PMC] [Abstract]
- "LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells."Biochem. Biophys. Res. Commun. 371:333-338(2008) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
- "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
- "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]